These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 19345579)
1. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles. Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and PKCtheta inhibitory activity of a series of 5-vinyl phenyl sulfonamide-3-pyridinecarbonitriles. Shim J; Eid C; Lee J; Liu E; Chaudhary D; Boschelli DH Bioorg Med Chem Lett; 2009 Dec; 19(23):6575-7. PubMed ID: 19854645 [TBL] [Abstract][Full Text] [Related]
3. Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors. Boschelli DH; Wang D; Prashad AS; Subrath J; Wu B; Niu C; Lee J; Yang X; Brennan A; Chaudhary D Bioorg Med Chem Lett; 2009 Jul; 19(13):3623-6. PubMed ID: 19447612 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and PKCtheta inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitriles. Boschelli DH; Wu B; Barrios Sosa AC; Chen J; Asselin M; Cole DC; Lee J; Yang X; Chaudhary D Bioorg Med Chem Lett; 2008 May; 18(9):2850-3. PubMed ID: 18434148 [TBL] [Abstract][Full Text] [Related]
5. First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors. Niu C; Boschelli DH; Tumey LN; Bhagirath N; Subrath J; Shim J; Wang Y; Wu B; Eid C; Lee J; Yang X; Brennan A; Chaudhary D Bioorg Med Chem Lett; 2009 Oct; 19(20):5829-32. PubMed ID: 19762237 [TBL] [Abstract][Full Text] [Related]
6. 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCtheta. Nathan Tumey L; Boschelli DH; Lee J; Chaudhary D Bioorg Med Chem Lett; 2008 Aug; 18(15):4420-3. PubMed ID: 18606543 [TBL] [Abstract][Full Text] [Related]
7. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors. Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200 [TBL] [Abstract][Full Text] [Related]
8. 5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCtheta: optimization of enzymatic and functional activity. Tumey LN; Bhagirath N; Brennan A; Brooijmans N; Lee J; Yang X; Boschelli DH Bioorg Med Chem; 2009 Dec; 17(23):7933-48. PubMed ID: 19884013 [TBL] [Abstract][Full Text] [Related]
9. C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I. Subrath J; Wang D; Wu B; Niu C; Boschelli DH; Lee J; Yang X; Brennan A; Chaudhary D Bioorg Med Chem Lett; 2009 Sep; 19(18):5423-5. PubMed ID: 19682896 [TBL] [Abstract][Full Text] [Related]
10. C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part II. Prashad AS; Wang D; Subrath J; Wu B; Lin M; Zhang MY; Kagan N; Lee J; Yang X; Brennan A; Chaudhary D; Xu X; Leung L; Wang J; Boschelli DH Bioorg Med Chem Lett; 2009 Oct; 19(19):5799-802. PubMed ID: 19703774 [TBL] [Abstract][Full Text] [Related]
11. Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCtheta inhibitors. Wu B; Boschelli DH; Lee J; Yang X; Chaudhary D Bioorg Med Chem Lett; 2009 Feb; 19(3):766-9. PubMed ID: 19111463 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase. Kim DK; Lim JH; Lee JA; Dewang PM Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921 [TBL] [Abstract][Full Text] [Related]
13. Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitors. Boschelli DH; Subrath J; Niu C; Wu B; Wang Y; Lee J; Brennan A; Ho M; Deng B; Yang X; Xu X; Leung L; Wang J; Atherton J; Chaudhary D Bioorg Med Chem Lett; 2010 Mar; 20(6):1965-8. PubMed ID: 20153643 [TBL] [Abstract][Full Text] [Related]
14. Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases. Jimenez JM; Boyall D; Brenchley G; Collier PN; Davis CJ; Fraysse D; Keily SB; Henderson J; Miller A; Pierard F; Settimo L; Twin HC; Bolton CM; Curnock AP; Chiu P; Tanner AJ; Young S J Med Chem; 2013 Mar; 56(5):1799-810. PubMed ID: 23398373 [TBL] [Abstract][Full Text] [Related]
15. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors. Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors. Huang H; Hutta DA; Hu H; DesJarlais RL; Schubert C; Petrounia IP; Chaikin MA; Manthey CL; Player MR Bioorg Med Chem Lett; 2008 Apr; 18(7):2355-61. PubMed ID: 18342505 [TBL] [Abstract][Full Text] [Related]